Literature DB >> 17468652

High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease.

Enitan D Carrol1, Malcolm Guiver, Standwell Nkhoma, Limangeni A Mankhambo, John Marsh, Paul Balmer, Daniel L Banda, Graham Jeffers, Sarah A White, Elizabeth M Molyneux, Malcolm E Molyneux, Rosalind L Smyth, C Anthony Hart.   

Abstract

BACKGROUND: In bacteremia owing to Streptococcus pneumoniae, high bacterial counts at presentation have been shown to be predictive of the development of serious invasive disease. Using real-time PCR, we aimed to determine pneumococcal DNA loads in blood and CSF, and their relationship to cytokine concentrations, clinical presentation and outcome.
METHODS: Children with confirmed meningitis (n = 82) or pneumonia (n = 13) were prospectively recruited, and blood and CSF samples taken for pneumococcal bacterial DNA loads and cytokine determination.
RESULTS: At the time of admission, the median bacterial load in blood was 1.6 x 10 DNA copies/mL (range 0.00-1.54 x 10) and in CSF it was 5.77 x 10 DNA copies/mL (range 4.42 x 10 to 6.15 x 10). Median blood and CSF bacterial loads (log DNA copies/mL) were significantly higher in nonsurvivors than in survivors; blood (3.80 vs. 2.97, P = 0.003), CSF (8.17 vs. 7.50, P = 0.03). In HIV-infected children (n = 59), blood and CSF loads and plasma tumor necrosis factor-alpha, interleukin-1beta (IL-1beta), IL-6 and IL-10 were all significantly higher in nonsurvivors than in survivors, but in HIV-uninfected children (n = 36) this difference was not significant. Blood bacterial loads and plasma cytokine concentrations were significantly associated, and were all significantly higher in children with meningitis than in those with pneumonia. In children with meningitis, median CSF cytokine concentrations were significantly higher than median plasma cytokine concentrations (P < 0.001) and CSF bacterial loads were significantly associated with CSF IL-1beta (P = 0.002) and IL-10 (P = 0.001) concentrations.
CONCLUSIONS: Pneumococcal DNA loads are associated with plasma cytokine concentrations, and are higher in meningitis than in pneumonia. High blood and CSF pneumococcal DNA loads are associated with a fatal outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468652      PMCID: PMC2810843          DOI: 10.1097/01.inf.0000260253.22994.61

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  28 in total

Review 1.  Cytokines and chemokines in meningeal inflammation: biology and clinical implications.

Authors:  M G Täuber; B Moser
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Uwe Koedel; William Michael Scheld; Hans-Walter Pfister
Journal:  Lancet Infect Dis       Date:  2002-12       Impact factor: 25.071

3.  Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

Authors:  F Dallaire; N Ouellet; Y Bergeron; V Turmel; M C Gauthier; M Simard; M G Bergeron
Journal:  J Infect Dis       Date:  2001-06-26       Impact factor: 5.226

Review 4.  Cytokines and the central nervous system.

Authors:  J Szelényi
Journal:  Brain Res Bull       Date:  2001-03-01       Impact factor: 4.077

5.  Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.

Authors:  E Wang; M Simard; N Ouellet; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

6.  Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.

Authors:  C E Corless; M Guiver; R Borrow; V Edwards-Jones; A J Fox; E B Kaczmarski
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

7.  HIV infection among paediatric in-patients in Blantyre, Malawi.

Authors:  Sheryle R Rogerson; Melissa Gladstone; Maria Callaghan; Laura Erhart; Stephen J Rogerson; Eric Borgstein; Robin L Broadhead
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-09       Impact factor: 2.184

8.  The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi.

Authors:  E M Molyneux; M Tembo; K Kayira; L Bwanaisa; J Mweneychanya; A Njobvu; H Forsyth; S Rogerson; A L Walsh; M E Molyneux
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

9.  Detection and quantitation of bacteremia in childhood.

Authors:  M Santosham; E R Moxon
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

10.  Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis.

Authors:  W E Feldman; C M Ginsburg; G H McCracken; D Allen; P Ahmann; J Graham; L Graham
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

View more
  50 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 2.  Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes.

Authors:  K Z Vardakas; F I Anifantaki; K K Trigkidis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-02       Impact factor: 3.267

3.  DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema.

Authors:  Carmen Muñoz-Almagro; Sandra Gala; Laura Selva; Iolanda Jordan; David Tarragó; Roman Pallares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-24       Impact factor: 3.267

4.  High levels of mecA DNA detected by a quantitative real-time PCR assay are associated with mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Ya-Chi Ho; Shan-Chwen Chang; Su-Ru Lin; Wei-Kung Wang
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

5.  Improved sensitivity for molecular detection of bacterial and Candida infections in blood.

Authors:  Andrea Bacconi; Gregory S Richmond; Michelle A Baroldi; Thomas G Laffler; Lawrence B Blyn; Heather E Carolan; Mark R Frinder; Donna M Toleno; David Metzgar; Jose R Gutierrez; Christian Massire; Megan Rounds; Natalie J Kennel; Richard E Rothman; Stephen Peterson; Karen C Carroll; Teresa Wakefield; David J Ecker; Rangarajan Sampath
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

Review 6.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

7.  Pathogen replication, host inflammation, and disease in the upper respiratory tract.

Authors:  Michael J Mina; Keith P Klugman
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

8.  PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis.

Authors:  Tomer Avni; Nariman Mansur; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

9.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection.

Authors:  Enitan D Carrol; Limangeni A Mankhambo; Graham Jeffers; Deborah Parker; Malcolm Guiver; Paul Newland; Daniel L Banda; Elizabeth M Molyneux; Robert S Heyderman; Malcolm E Molyneux; C Anthony Hart
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.